Periodic Reporting for period 4 - Novel asthma therapy (Biocompatible nanoparticles for T cell targeted siRNA delivery as novel asthma therapy)

The goal of the project NOVEL ASTHMA THERAPY is to develop new therapies for the treatment of asthma that address the underlying immunologic imbalance of T-helper-cells Type 2 (Th2) responses toward allergens. We have so far addressed the problem of targeting T cells with...